Overcoming the Obstacles to Rare Drug Approval
This article was originally published in SRA
Executive Summary
Gaining approval for drugs for very rare diseases can be difficult for small companies with limited resources. Using outside regulatory expertise can help to smooth the way, say Gerald Haase,Osian Edwards and Jean Vincent.